Thrombolytic Drug Market by Types (Fibrin Specific Drugs, Nonfibrin-Specific Drugs), Category (Abbokinase, Eminase, RETAVASE), Distribution Channel - Global Forecast 2023-2030

1. AstraZeneca PLC
2. Becton
Dickinson and Company (BD)
3. Boehringer Ingelheim International GmbH
4. Boston Scientific Corporation
5. Chiesi Farmaceutici S.P.A.
6. Eli Lilly and Company
7. Medtronic PLC
8. Microbix Biosystems Inc.
9. Pfizer Inc.
10. Sanofi S.A.
11. Siemens Healthineers AG
12. Sigma-Aldrich Corporation
13. Synergy Medical Inc
14. Taj Pharmaceuticals Ltd.
15. Teleflex Incorporated